MYBL2 and triple-negative breast carcinoma: MYBL2-induced PITPNA antisense RNA 1 (PITPNA-AS1) upregulates salt-inducible kinase 2 (SIK2) to exert oncogenic functions in triple-negative breast cancer [14].